Related Experiment Videos
Quantitative electroencephalography in OCD patients treated with paroxetine
Elsebet S Hansen1, Leslie S Prichep, Tom G Bolwig
1Neuroscience Centre, Dept. of Psychiatry, Copenhagen University, Copenhagen, Denmark.
Clinical EEG (Electroencephalography)
|June 6, 2003
Summary
Quantitative electroencephalography (QEEG) can predict treatment response in obsessive-compulsive disorder (OCD) patients. Patients with high baseline alpha activity are likely to respond to serotonin reuptake inhibitors (SSRIs).
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Obsessive-compulsive disorder (OCD) treatment has improved with serotonergic drugs.
- Brain imaging and biochemical studies suggest basal ganglia, cortical, and thalamic involvement in OCD.
- Previous QEEG neurometric studies identified two OCD subtypes with differential SSRI response.
Purpose of the Study:
- To use neurometric QEEG to subtype non-depressed OCD patients treated with paroxetine.
- To evaluate the predictive value of QEEG subtypes for SSRI treatment response.
Main Methods:
- Quantitative electroencephalography (QEEG) was used to analyze brain activity in 20 non-depressed OCD patients.
- Patients were treated with paroxetine, and treatment response was assessed.
- QEEG data were compared to a normative population and analyzed for baseline activity patterns.
Main Results:
- 18 out of 20 OCD patients responded to paroxetine treatment.
- 94.4% of responders exhibited a QEEG profile with high relative alpha baseline activity.
- Successful treatment led to a decrease in alpha activity towards normal levels.
- Non-responders did not show the characteristic theta excess seen in previous studies.
Conclusions:
- QEEG neurometrics can effectively subtype OCD patients.
- Baseline QEEG alpha activity is a strong predictor of SSRI treatment response in OCD.
- QEEG offers a valuable tool for personalizing OCD treatment strategies.